-
"One of the nation's premier plaintiffs' firms."
American Lawyer
-
"Representing the best qualities of the plaintiffs' bar."
The National Law Journal
-
"Their effective and caring advocacy for clients has earned Lieff Cabraser its first-class reputation."
The Daily Journal
Media Center
Medtronic Infuse News: Fallout From Back Surgery Product Case Prompting Reforms
Milwaukee Wisconsin Journal Sentinel
December 29, 2011
Even before it went on the market in 2002, doctors were talking about how the back surgery product known as bone morphogenetic protein-2 would revolutionize medicine.
It did -- but in ways no one imagined.
Instead of offering 100% success in fusing ailing spines with virtually no complications, BMP-2 became a biotech breakthrough associated with skepticism and scandal, epitomizing questions over whether corporate-funded research carried out by financially conflicted doctors can be trusted.
The saga of BMP-2 is prompting bedrock reforms in the policies of medical journals as well as changes in public attitudes about medical research. Experts say the controversy offers some promise that the business of developing new medicine and treatments will become more transparent and credible.
Until just a few years ago, some medical journals and the doctors who wrote papers often failed to disclose financial conflicts or spell out how conclusions about how a product's safety and effectiveness were reached.
Read the full article on the Milwaukee Wisconsin Journal Sentinel.